Published in PLoS One on September 27, 2012
Epstein-Barr virus in systemic lupus erythematosus, rheumatoid arthritis and multiple sclerosis—association and causation. Viruses (2012) 0.93
Contribution of vitamin D insufficiency to the pathogenesis of multiple sclerosis. Ther Adv Neurol Disord (2013) 0.89
Multiple sclerosis: autoimmunity and viruses. Curr Opin Rheumatol (2013) 0.89
Activation of MSRV-type endogenous retroviruses during infectious mononucleosis and Epstein-Barr virus latency: the missing link with multiple sclerosis? PLoS One (2013) 0.85
Endogenous retroviruses and multiple sclerosis-new pieces to the puzzle. BMC Neurol (2013) 0.84
Human Endogenous Retrovirus and Neuroinflammation in Chronic Inflammatory Demyelinating Polyradiculoneuropathy. EBioMedicine (2016) 0.83
Preclinical and early clinical development of GNbAC1, a humanized IgG4 monoclonal antibody targeting endogenous retroviral MSRV-Env protein. MAbs (2015) 0.83
Role of pathogens in multiple sclerosis. Int Rev Immunol (2013) 0.82
Inflammatory response of endothelial cells to a human endogenous retrovirus associated with multiple sclerosis is mediated by TLR4. Int Immunol (2015) 0.82
HERV-W polymorphism in chromosome X is associated with multiple sclerosis risk and with differential expression of MSRV. Retrovirology (2014) 0.81
Multiple Sclerosis between Genetics and Infections: Human Endogenous Retroviruses in Monocytes and Macrophages. Front Immunol (2015) 0.80
Transcriptional derepression of the ERVWE1 locus following influenza A virus infection. J Virol (2014) 0.79
Natalizumab Therapy Modulates miR-155, miR-26a and Proinflammatory Cytokine Expression in MS Patients. PLoS One (2016) 0.77
Cannabis use by individuals with multiple sclerosis: effects on specific immune parameters. Inflammopharmacology (2014) 0.77
Multiple sclerosis: an example of pathogenic viral interaction? Virol J (2017) 0.75
The association between human endogenous retroviruses and multiple sclerosis: A systematic review and meta-analysis. PLoS One (2017) 0.75
Multiple sclerosis retrovirus-like envelope gene: Role of the chromosome 20 insertion. BBA Clin (2015) 0.75
HBV X Protein induces overexpression of HERV-W env through NF-κB in HepG2 cells. Virus Genes (2017) 0.75
Type W Human Endogenous Retrovirus (HERV-W) Integrations and Their Mobilization by L1 Machinery: Contribution to the Human Transcriptome and Impact on the Host Physiopathology. Viruses (2017) 0.75
An ancestral retroviral protein identified as a therapeutic target in type-1 diabetes. JCI Insight (2017) 0.75
Basic local alignment search tool. J Mol Biol (1990) 659.07
Recommended diagnostic criteria for multiple sclerosis: guidelines from the International Panel on the diagnosis of multiple sclerosis. Ann Neurol (2001) 24.36
Syncytin is a captive retroviral envelope protein involved in human placental morphogenesis. Nature (2000) 7.37
Epstein-Barr virus infection is not a characteristic feature of multiple sclerosis brain. Brain (2009) 3.04
Dysregulated Epstein-Barr virus infection in the multiple sclerosis brain. J Exp Med (2007) 2.88
Human endogenous retrovirus glycoprotein-mediated induction of redox reactants causes oligodendrocyte death and demyelination. Nat Neurosci (2004) 2.64
Survey of human genes of retroviral origin: identification and transcriptome of the genes with coding capacity for complete envelope proteins. J Virol (2003) 2.31
Monocyte activation and differentiation augment human endogenous retrovirus expression: implications for inflammatory brain diseases. Ann Neurol (2001) 2.16
Molecular identification of a novel retrovirus repeatedly isolated from patients with multiple sclerosis. The Collaborative Research Group on Multiple Sclerosis. Proc Natl Acad Sci U S A (1997) 1.97
Clinical features and viral serologies in children with multiple sclerosis: a multinational observational study. Lancet Neurol (2007) 1.88
RNA interference directed against viral and cellular targets inhibits human immunodeficiency Virus Type 1 replication. J Virol (2002) 1.80
Human endogenous retrovirus type W envelope expression in blood and brain cells provides new insights into multiple sclerosis disease. Mult Scler (2012) 1.77
Epstein-Barr virus transactivates the human endogenous retrovirus HERV-K18 that encodes a superantigen. Immunity (2001) 1.75
Epstein-barr virus infection and multiple sclerosis: a review. J Neuroimmune Pharmacol (2010) 1.74
CNS inflammation and macrophage/microglial biology associated with HIV-1 infection. J Neuroimmune Pharmacol (2009) 1.73
Detection of virion-associated MSRV-RNA in serum of patients with multiple sclerosis. Lancet (1998) 1.61
Effects of infectious mononucleosis and HLA-DRB1*15 in multiple sclerosis. Mult Scler (2009) 1.56
Processed pseudogenes of human endogenous retroviruses generated by LINEs: their integration, stability, and distribution. Genome Res (2002) 1.54
Astrocytes--friends or foes in multiple sclerosis? Glia (2007) 1.52
Brains and peripheral blood mononuclear cells of multiple sclerosis (MS) patients hyperexpress MS-associated retrovirus/HERV-W endogenous retrovirus, but not Human herpesvirus 6. J Gen Virol (2007) 1.50
The envelope glycoprotein of human endogenous retrovirus type W uses a divergent family of amino acid transporters/cell surface receptors. J Virol (2002) 1.49
The envelope protein of a human endogenous retrovirus-W family activates innate immunity through CD14/TLR4 and promotes Th1-like responses. J Immunol (2006) 1.39
An updated meta-analysis of risk of multiple sclerosis following infectious mononucleosis. PLoS One (2010) 1.36
The blood-brain barrier induces differentiation of migrating monocytes into Th17-polarizing dendritic cells. Brain (2007) 1.36
Anti-Epstein-Barr virus antibodies as serological markers of multiple sclerosis: a prospective study among United States military personnel. Mult Scler (2011) 1.24
Epstein-Barr virus binding to CD21 activates the initial viral promoter via NF-kappaB induction. J Exp Med (1997) 1.23
Human endogenous retrovirus (HERV)-W ENV and GAG proteins: physiological expression in human brain and pathophysiological modulation in multiple sclerosis lesions. J Neurovirol (2005) 1.19
The human endogenous retrovirus link between genes and environment in multiple sclerosis and in multifactorial diseases associating neuroinflammation. Clin Rev Allergy Immunol (2010) 1.19
Elevated Epstein-Barr virus-encoded nuclear antigen-1 immune responses predict conversion to multiple sclerosis. Ann Neurol (2010) 1.17
Claudin-1 induced sealing of blood-brain barrier tight junctions ameliorates chronic experimental autoimmune encephalomyelitis. Acta Neuropathol (2011) 1.16
Transactivation of elements in the human endogenous retrovirus W family by viral infection. Retrovirology (2006) 1.16
Leptomeningeal cell line from multiple sclerosis with reverse transcriptase activity and viral particles. Res Virol (1990) 1.13
Molecular cloning and characterization of MSRV-related sequences associated with retrovirus-like particles. Virology (1999) 1.12
Human endogenous retroviruses and multiple sclerosis: innocent bystanders or disease determinants? Biochim Biophys Acta (2010) 1.11
Novel reliable real-time PCR for differential detection of MSRVenv and syncytin-1 in RNA and DNA from patients with multiple sclerosis. J Virol Methods (2009) 1.06
The multiple sclerosis-associated retrovirus and its HERV-W endogenous family: a biological interface between virology, genetics, and immunology in human physiology and disease. J Neurovirol (2008) 1.05
Multiple sclerosis-associated retrovirus (MSRV) in Sardinian MS patients. Neurology (2002) 1.05
Multiple sclerosis-associated retrovirus and progressive disability of multiple sclerosis. Mult Scler (2010) 1.03
B cells and monocytes from patients with active multiple sclerosis exhibit increased surface expression of both HERV-H Env and HERV-W Env, accompanied by increased seroreactivity. Retrovirology (2009) 1.03
Multiple sclerosis-associated retrovirus in early multiple sclerosis: a six-year follow-up of a Sardinian cohort. Mult Scler (2006) 1.01
Identification and characterization of complement C3 receptors on human astrocytes. J Immunol (1996) 1.01
Analysis of transcribed human endogenous retrovirus W env loci clarifies the origin of multiple sclerosis-associated retrovirus env sequences. Retrovirology (2009) 1.00
Epstein-Barr virus and multiple sclerosis. J Neurol Neurosurg Psychiatry (2011) 1.00
Multiple sclerosis after infectious mononucleosis: record linkage study. J Epidemiol Community Health (2004) 1.00
Multiple sclerosis-associated retrovirus particles cause T lymphocyte-dependent death with brain hemorrhage in humanized SCID mice model. J Neurovirol (2003) 0.99
Binding of the Epstein-Barr virus major envelope glycoprotein gp350 results in the upregulation of the TNF-alpha gene expression in monocytic cells via NF-kappaB involving PKC, PI3-K and tyrosine kinases. J Mol Biol (2000) 0.99
Multiple sclerosis: a battle between destruction and repair. J Neurochem (2006) 0.99
HIV-1 clade B and C isolates exhibit differential replication: relevance to macrophage-mediated neurotoxicity. Neurotox Res (2011) 0.98
Epstein-Barr virus latent membrane protein LMP-2A is sufficient for transactivation of the human endogenous retrovirus HERV-K18 superantigen. J Virol (2004) 0.96
Signal pathways in astrocytes activated by cross-talk between of astrocytes and mast cells through CD40-CD40L. J Neuroinflammation (2011) 0.96
Unreliable real-time PCR analysis of human endogenous retrovirus-W (HERV-W) RNA expression and DNA copy number in multiple sclerosis. AIDS Res Hum Retroviruses (2009) 0.96
Relation between Epstein-Barr virus and multiple sclerosis: analytic study of scientific production. Eur J Clin Microbiol Infect Dis (2010) 0.95
Regulation of human endogenous retrovirus W protein expression by herpes simplex virus type 1: implications for multiple sclerosis. J Neurovirol (2006) 0.94
Inhibition of multiple-sclerosis-associated retrovirus as biomarker of interferon therapy. J Neurovirol (2008) 0.94
An N-terminally truncated envelope protein encoded by a human endogenous retrovirus W locus on chromosome Xq22.3. Retrovirology (2010) 0.93
Activation of the human endogenous retrovirus W long terminal repeat by herpes simplex virus type 1 immediate early protein 1. Mol Cells (2003) 0.93
In vitro modulation of the multiple sclerosis (MS)-associated retrovirus by cytokines: implications for MS pathogenesis. J Neurovirol (2003) 0.93
Role of natural killer cells in the pathogenesis and progression of multiple sclerosis. Pharmacol Res (2007) 0.92
Human herpesvirus-6B induces expression of the human endogenous retrovirus K18-encoded superantigen. J Clin Virol (2009) 0.92
Cutting edge: Epstein-Barr virus transactivates the HERV-K18 superantigen by docking to the human complement receptor 2 (CD21) on primary B cells. J Immunol (2006) 0.92
Epstein-Barr virus infection of human astrocyte cell lines. J Virol (1999) 0.91
Effects of interferon-beta therapy on innate and adaptive immune responses to the human endogenous retroviruses HERV-H and HERV-W, cytokine production, and the lectin complement activation pathway in multiple sclerosis. J Neuroimmunol (2009) 0.90
HHV-6A infection induces expression of HERV-K18-encoded superantigen. J Clin Virol (2009) 0.90
Multiple Sclerosis and HERV-W/MSRV: A Multicentric Study. Int J Biomed Sci (2007) 0.89
Herpes simplex virus ICP0 and ICP4 immediate early proteins strongly enhance expression of a retrovirus harboured by a leptomeningeal cell line from a patient with multiple sclerosis. J Gen Virol (1993) 0.89
Particle-associated retroviral RNA and tandem RGH/HERV-W copies on human chromosome 7q: possible components of a 'chain-reaction' triggered by infectious agents in multiple sclerosis? J Neurovirol (2000) 0.89
Classical immunomodulatory therapy in multiple sclerosis: how it acts, how it works. Arq Neuropsiquiatr (2011) 0.89
Endogenous retroviruses and human disease. Expert Rev Clin Immunol (2006) 0.89
Multiple sclerosis-associated virus-related pol sequences found both in multiple sclerosis and healthy donors are more frequently expressed in multiple sclerosis patients. J Neurovirol (2003) 0.88
Multiple sclerosis-associated retrovirus and MS prognosis: an observational study. Neurology (2002) 0.88
A systematic evaluation of expression of HERV-W elements; influence of genomic context, viral structure and orientation. BMC Genomics (2011) 0.87
Multiple sclerosis-associated retrovirus and optic neuritis. Mult Scler (2006) 0.86
Regulation of the syncytin-1 promoter in human astrocytes by multiple sclerosis-related cytokines. Virology (2007) 0.86
Mathematical modelling the age dependence of Epstein-Barr virus associated infectious mononucleosis. Math Med Biol (2011) 0.85
Inhibition of HIV replication by the plasminogen activator is dependent on vitronectin-mediated cell adhesion. J Leukoc Biol (2007) 0.85
Analysis of viral and genetic factors in South African patients with multiple sclerosis. Metab Brain Dis (2006) 0.85
Multiple sclerosis and multiple sclerosis-associated retrovirus in Sardinia. Neurol Sci (2001) 0.85
Changes in region- and cell type-specific expression patterns of neutral amino acid transporter 1 (ASCT-1) in the anterior cingulate cortex and hippocampus in schizophrenia, bipolar disorder and major depression. J Neural Transm (Vienna) (2006) 0.84
EBV LMP-2A employs a novel mechanism to transactivate the HERV-K18 superantigen through its ITAM. Virology (2008) 0.83
Age- and disease-dependent HERV-W envelope allelic variation in brain: association with neuroimmune gene expression. PLoS One (2011) 0.82
Type III and I interferons increase HIV uptake and replication in human cells that overexpress CD4, CCR5, and CXCR4. AIDS Res Hum Retroviruses (2008) 0.81
Epstein-Barr Virus and MS. Int MS J (2011) 0.76
Epstein-Barr Virus and MS:Causality or Association? Int MS J (2011) 0.76
Controversial role of Epstein-Barr virus in multiple sclerosis. Appl Immunohistochem Mol Morphol (2011) 0.76
Variants within the immunoregulatory CBLB gene are associated with multiple sclerosis. Nat Genet (2010) 4.69
Phenotype, localization, and mechanism of suppression of CD4(+)CD25(+) human thymocytes. J Exp Med (2002) 3.47
Genomic approach for analysis of surface proteins in Chlamydia pneumoniae. Infect Immun (2002) 1.94
Human CD8+CD25+ thymocytes share phenotypic and functional features with CD4+CD25+ regulatory thymocytes. Blood (2003) 1.79
Human endogenous retrovirus type W envelope expression in blood and brain cells provides new insights into multiple sclerosis disease. Mult Scler (2012) 1.77
The worldwide prevalence of multiple sclerosis. Clin Neurol Neurosurg (2002) 1.72
Active tuberculosis in Africa is associated with reduced Th1 and increased Th2 activity in vivo. Eur J Immunol (2002) 1.61
Brains and peripheral blood mononuclear cells of multiple sclerosis (MS) patients hyperexpress MS-associated retrovirus/HERV-W endogenous retrovirus, but not Human herpesvirus 6. J Gen Virol (2007) 1.50
Th2 cells are less susceptible than Th1 cells to the suppressive activity of CD25+ regulatory thymocytes because of their responsiveness to different cytokines. Blood (2003) 1.32
The glycopeptide CSF114(Glc) detects serum antibodies in multiple sclerosis. J Neuroimmunol (2005) 1.13
Safety and tolerability in relapsing-remitting multiple sclerosis patients treated with high-dose subcutaneous interferon-beta by Rebiject autoinjection over a 1-year period: the CoSa study. Clin Neuropharmacol (2008) 1.08
Human immunodeficiency virus-1 tat induces hyperproliferation and dysregulation of renal glomerular epithelial cells. Am J Pathol (2002) 1.08
Novel reliable real-time PCR for differential detection of MSRVenv and syncytin-1 in RNA and DNA from patients with multiple sclerosis. J Virol Methods (2009) 1.06
Functionalized multiwalled carbon nanotubes as ultrasound contrast agents. Proc Natl Acad Sci U S A (2012) 1.00
Molecular analysis, pathogenic mechanisms, and readthrough therapy on a large cohort of Kabuki syndrome patients. Hum Mutat (2014) 0.99
Evidence of early childhood as the susceptibility period in multiple sclerosis: space-time cluster analysis in a Sardinian population. Am J Epidemiol (2006) 0.98
Anti-cyclic citrullinated peptide antibodies are highly associated with severe bone lesions in rheumatoid arthritis anti-CCP and bone damage in RA. Autoimmunity (2004) 0.96
Functionalized carbon nanotubes as immunomodulator systems. Biomaterials (2013) 0.95
Infectious diseases and autoimmunity. J Infect Dev Ctries (2011) 0.94
Inhibition of multiple-sclerosis-associated retrovirus as biomarker of interferon therapy. J Neurovirol (2008) 0.94
GSTT1 and GSTM1 gene polymorphisms and gastric cancer in a high-risk italian population. Int J Cancer (2005) 0.94
In vitro modulation of the multiple sclerosis (MS)-associated retrovirus by cytokines: implications for MS pathogenesis. J Neurovirol (2003) 0.93
Oligosaccharides in colostrum of Italian and Burkinabe women. J Pediatr Gastroenterol Nutr (2006) 0.91
Increasing incidence of multiple sclerosis in the province of Sassari, northern Sardinia. Neuroepidemiology (2005) 0.89
Multiple Sclerosis and HERV-W/MSRV: A Multicentric Study. Int J Biomed Sci (2007) 0.89
Acute exposure to ethanol potentiates human immunodeficiency virus type 1 Tat-induced Ca(2+) overload and neuronal death in cultured rat cortical neurons. J Neurovirol (2006) 0.87
Regulation of the syncytin-1 promoter in human astrocytes by multiple sclerosis-related cytokines. Virology (2007) 0.86
C/EBPbeta regulates human immunodeficiency virus 1 gene expression through its association with cdk9. J Gen Virol (2007) 0.86
SNAP-25 single nucleotide polymorphisms are associated with hyperactivity in autism spectrum disorders. Pharmacol Res (2011) 0.86
SF2/ASF binding region within JC virus NCCR limits early gene transcription in glial cells. Virol J (2013) 0.86
Multiple sclerosis in twins from continental Italy and Sardinia: a nationwide study. Ann Neurol (2006) 0.86
Activation of MSRV-type endogenous retroviruses during infectious mononucleosis and Epstein-Barr virus latency: the missing link with multiple sclerosis? PLoS One (2013) 0.85
Ex vivo impact of functionalized carbon nanotubes on human immune cells. Nanomedicine (Lond) (2011) 0.85
Extinction of Tumor Antigen Expression by SF2/ASF in JCV-Transformed Cells. Genes Cancer (2011) 0.85
NRAMP1 polymorphism and viral factors in Sardinian multiple sclerosis patients. Can J Neurol Sci (2008) 0.84
Routine use of simultaneous laparoendoscopic approach in patients with confirmed gallbladder and bile duct stones: fit for laparoscopy fit for "rendezvous". World J Surg (2013) 0.83
Neuropsycological gender differences in healthy individuals and in pediatric neurodevelopmental disorders. A role for SNAP-25. Med Hypotheses (2009) 0.83
Clustering of multiple sclerosis, age of onset and gender in Sardinia. J Neurol Sci (2009) 0.82
Anti-inflammatory nuclear receptor superfamily in multiple sclerosis patients from Sardinia and Sweden. Neurobiol Dis (2005) 0.82
Plasma chitotriosidase in health and pathology. Clin Lab (2007) 0.82
HLA polymorphisms in Italian children with autism spectrum disorders: results of a family based linkage study. J Neuroimmunol (2010) 0.82
Family-based transmission analysis of HLA genetic markers in Sardinian children with autistic spectrum disorders. Hum Immunol (2009) 0.81
Natalizumab inhibits the expression of human endogenous retroviruses of the W family in multiple sclerosis patients: a longitudinal cohort study. Mult Scler (2013) 0.81
Cytoskeletal proteins in the cerebrospinal fluid as biomarker of multiple sclerosis. Neurol Sci (2012) 0.81
Analysis of 45 candidate genes for disease modifying activity in multiple sclerosis. J Neurol (2008) 0.81
Type III and I interferons increase HIV uptake and replication in human cells that overexpress CD4, CCR5, and CXCR4. AIDS Res Hum Retroviruses (2008) 0.81
HIV Tat acts on endogenous retroviruses of the W family and this occurs via Toll-like receptor 4: inference for neuroAIDS. AIDS (2014) 0.80
Variation of the myelin oligodendrocyte glycoprotein gene is not primarily associated with multiple sclerosis in the Sardinian population. BMC Genet (2007) 0.80
Protein-protein interaction analysis highlights additional loci of interest for multiple sclerosis. PLoS One (2012) 0.80
Self-perceived physical functioning and health status among fully ambulatory multiple sclerosis patients. J Neurol (2008) 0.79
[Correlation between different clinical activity and anti CC-P (anti-cyclic citrullinated peptide antibodies) titres in rheumatoid arthritis treated with three different tumor necrosis factors TNF-alpha blockers]. Recenti Prog Med (2006) 0.79
Immunomodulatory properties of carbon nanotubes are able to compensate immune function dysregulation caused by microgravity conditions. Nanoscale (2014) 0.78
A family based linkage analysis of HLA and 5-HTTLPR gene polymorphisms in Sardinian children with autism spectrum disorder. Hum Immunol (2006) 0.78
Chitotriosidase in multiple sclerosis. Clin Immunol (2009) 0.77
Role of SH levels and markers of immune response in the stroke. Dis Markers (2013) 0.76
Investigation of a genetic variation of a variable number tandem repeat polymorphism of interleukin-6 gene in patients with multiple sclerosis. J Neurol (2003) 0.76
Multiple sclerosis in Northern Sardinia, Italy: a methodological approach for genetic epidemiological studies. Neuroepidemiology (2003) 0.76
High frequency of TNF alleles -238A and -376A in individuals from northern Sardinia. Cytokine (2004) 0.76
Laparoscopic appendectomy performed by residents and experienced surgeons. JSLS (2009) 0.75
Immunological heterogeneity of multiple sclerosis in Sardinia and Sweden. Mult Scler (2005) 0.75
Re: Errors in the editorial by Christensen and Giovannoni [HERVs: have we been here before? MSJ 18(12) 1670-1672]. Mult Scler (2013) 0.75
Characterization of an HIV type 1 strain with preferential replication in adherent cells. AIDS Res Hum Retroviruses (2002) 0.75
Unsung hero Robert C. Gallo. Science (2009) 0.75
The aliens inside human DNA: HERV-W/MSRV/syncytin-1 endogenous retroviruses and neurodegeneration. J Infect Dev Ctries (2015) 0.75
Role of low nuclear grading of renal carcinoma cells in the functional profile of tumor-infiltrating T cells. Int J Cancer (2002) 0.75
Endoscopic haemostasis of lower gastrointestinal bleeding from an ileocolonic anastomosis constructed using a biofragmentable anastomotic ring. Chir Ital (2004) 0.75